Fig. 2: Treatment outcomes for IgH translocation and trisomies groups. | Blood Cancer Journal

Fig. 2: Treatment outcomes for IgH translocation and trisomies groups.

From: Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

Fig. 2

Comparison of a overall response rate, b ≥VGPR rate, and c time to next treatment with PI-based (blue), IMiD-based (red), PI + IMiD-based (green) and other (purple) first-line treatments for patients with IgH translocations (without trisomies), trisomies (without IgH translocations) and patients with both IgH translocations and trisomies. IgH immunoglobulin heavy chain, IMiD immunomodulatory drug, PI proteasome inhibitor, trans translocation, VGPR very good partial response.

Back to article page